The use of multimeric ligands is considered as a promising strategy to improve tumor targeting for diagnosis and therapy. Herein, tetrameric RGD peptidomimetics were designed to target αvβ3 integrin-expressing tumor cells. These compounds were prepared via an oxime chemoselective assembly of cyclo(DKPRGD) ligands and a cyclodecapeptide scaffold that allows a tetrameric presentation. The resulting tetrameric RGD peptidomimetics were shown to improve αvβ3 integrin binding compared to the monomeric form. Interestingly, these compounds were also able to enhance tumor cell endocytosis in the same way as tetrameric RGD peptides. Altogether, the results show the potential of the tetrameric cyclo(DKP-RGD) ligands for in vivo imaging and drug delivery.
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake / A. Pina, M. Kadri, D. Arosio, A. Dal Corso, J. Coll, C. Gennari, D. Boturyn. - In: CHEMISTRY-A EUROPEAN JOURNAL. - ISSN 0947-6539. - 26:33(2020 Jun), pp. 7492-7496. [10.1002/chem.202001115]
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake
A. PinaPrimo
;A. Dal Corso;C. Gennari
Penultimo
;
2020
Abstract
The use of multimeric ligands is considered as a promising strategy to improve tumor targeting for diagnosis and therapy. Herein, tetrameric RGD peptidomimetics were designed to target αvβ3 integrin-expressing tumor cells. These compounds were prepared via an oxime chemoselective assembly of cyclo(DKPRGD) ligands and a cyclodecapeptide scaffold that allows a tetrameric presentation. The resulting tetrameric RGD peptidomimetics were shown to improve αvβ3 integrin binding compared to the monomeric form. Interestingly, these compounds were also able to enhance tumor cell endocytosis in the same way as tetrameric RGD peptides. Altogether, the results show the potential of the tetrameric cyclo(DKP-RGD) ligands for in vivo imaging and drug delivery.File | Dimensione | Formato | |
---|---|---|---|
POSTPRINT.pdf
Open Access dal 31/03/2021
Descrizione: Articolo principale
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
520.06 kB
Formato
Adobe PDF
|
520.06 kB | Adobe PDF | Visualizza/Apri |
chem.202001115.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
675 kB
Formato
Adobe PDF
|
675 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.